Palvella Therapeutics, Inc. (PVLA) Total liabilities 2016–2023
Palvella Therapeutics, Inc. (PVLA) total liabilities at each fiscal year-end, per SEC filings.
$11.4MFY2023 · since FY2016: $9.8M → $11.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | $11.4M | -83.1% |
| FY2022 | $67.6M | -34.3% |
| FY2021 | $102.8M | +39.0% |
| FY2020 | $74.0M | -17.6% |
| FY2019 | $89.7M | -11.5% |
| FY2018 | $101.4M | +9.8% |
| FY2017 | $92.4M | +838.9% |
| FY2016 | $9.8M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More PVLA financial trends
PVLA RevenuePVLA Net incomePVLA Net marginPVLA Gross profitPVLA Gross marginPVLA Operating incomePVLA Operating marginPVLA Operating cash flowPVLA Free cash flowPVLA Capital expendituresPVLA Return on equityPVLA Stock buybacksPVLA Dividends paidPVLA Total assetsPVLA Shareholders’ equityPVLA overview →